首页 > 最新文献

Clinical calcium最新文献

英文 中文
[Mineral metabolism and aging.] 矿物质代谢和衰老。
Pub Date : 2019-01-01 DOI: 10.20837/4201902165
Makoto Kuro-O

Analysis of a mutant mouse exhibiting accelerated aging identified phosphorus as a pro-aging factor in mammals. In the blood, phosphorus exists in the form of phosphate ions and colloidal particles composed of solid-phase calcium-phosphate and serum protein fetuin-A, which are termed calciprotein particles(CPP). Blood CPP levels increase with age and decline of renal function. Because CPP have the ability to induce inflammation and vascular smooth muscle cell calcification in vitro, we hypothesize that CPP may serve as a pathogen that accelerates aging. Therapeutic interventions in phosphate and/or CPP may open a new avenue for practical anti-aging medicine.

对表现出加速衰老的突变小鼠的分析表明,磷在哺乳动物中是一种促进衰老的因素。在血液中,磷以磷酸盐离子和固相磷酸钙与血清蛋白fetuin-A组成的胶体颗粒的形式存在,称为钙蛋白颗粒(calprotein particles, CPP)。血CPP水平随年龄和肾功能下降而升高。由于CPP在体外具有诱导炎症和血管平滑肌细胞钙化的能力,我们假设CPP可能作为加速衰老的病原体。磷酸盐和/或CPP的治疗干预可能为实际抗衰老药物开辟新的途径。
{"title":"[Mineral metabolism and aging.]","authors":"Makoto Kuro-O","doi":"10.20837/4201902165","DOIUrl":"https://doi.org/10.20837/4201902165","url":null,"abstract":"<p><p>Analysis of a mutant mouse exhibiting accelerated aging identified phosphorus as a pro-aging factor in mammals. In the blood, phosphorus exists in the form of phosphate ions and colloidal particles composed of solid-phase calcium-phosphate and serum protein fetuin-A, which are termed calciprotein particles(CPP). Blood CPP levels increase with age and decline of renal function. Because CPP have the ability to induce inflammation and vascular smooth muscle cell calcification in vitro, we hypothesize that CPP may serve as a pathogen that accelerates aging. Therapeutic interventions in phosphate and/or CPP may open a new avenue for practical anti-aging medicine.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"165-170"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Non-canonical Wnt signaling and cellular responses.] [非典型Wnt信号和细胞反应。]
Pub Date : 2019-01-01 DOI: 10.20837/4201903291
Michiru Nishita, Takeshi Saji, Yasuhiro Minami

Non-canonical Wnt signaling, including planar cell polarity and Ca2+ pathways, plays crucial roles in developmental processes, including morphogenesis and tissue-/organo-genesis, in animals. Ror2 receptor tyrosine kinase mediates non-canonical Wnt signaling by acting as a receptor for Wnt5a, which also inhibits canonical Wnt signaling. Dysregulation of Wnt5a-Ror2 signaling causes a wide range of developmental defects and cancer progression. Recently, Ror2-mediated non-canonical Wnt signaling has also been shown to induce formation of filopodia that facilitates transport of Wnt to neighboring cells, thereby activating canonical Wnt signaling there.

非规范Wnt信号,包括平面细胞极性和Ca2+通路,在动物的发育过程中起着至关重要的作用,包括形态发生和组织/器官发生。Ror2受体酪氨酸激酶通过作为Wnt5a受体介导非典型Wnt信号传导,Wnt5a也抑制典型Wnt信号传导。Wnt5a-Ror2信号的失调导致广泛的发育缺陷和癌症进展。最近,ror2介导的非规范Wnt信号也被证明可以诱导丝状足的形成,从而促进Wnt向邻近细胞的运输,从而激活那里的规范Wnt信号。
{"title":"[Non-canonical Wnt signaling and cellular responses.]","authors":"Michiru Nishita,&nbsp;Takeshi Saji,&nbsp;Yasuhiro Minami","doi":"10.20837/4201903291","DOIUrl":"https://doi.org/10.20837/4201903291","url":null,"abstract":"<p><p>Non-canonical Wnt signaling, including planar cell polarity and Ca<sup>2+</sup> pathways, plays crucial roles in developmental processes, including morphogenesis and tissue-/organo-genesis, in animals. Ror2 receptor tyrosine kinase mediates non-canonical Wnt signaling by acting as a receptor for Wnt5a, which also inhibits canonical Wnt signaling. Dysregulation of Wnt5a-Ror2 signaling causes a wide range of developmental defects and cancer progression. Recently, Ror2-mediated non-canonical Wnt signaling has also been shown to induce formation of filopodia that facilitates transport of Wnt to neighboring cells, thereby activating canonical Wnt signaling there.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 3","pages":"291-297"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37007571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
[The sequential therapy of romosozumab followed by denosumab for osteoporosis.] [罗莫索单抗加地诺单抗序贯治疗骨质疏松症。]
Pub Date : 2019-01-01 DOI: 10.20837/4201903357
Kumiko Ono, Sakae Tanaka

Romosozumab is a bone-forming agent with a dual effect of increasing bone formation and decreasing bone resorption by inhibiting sclerostin. In the pivotal Fracture study in postmenopausal women with osteroposis(FRAME)and the extension trial, 12 months of romosozumab led to persistent fracture, especially new vertebral fracture, reduction benefit and ongoing BMD(bone mineral density)gains when follow 24 months of denosumab. The sequence therapy of romosozumab followed by denosumab may be a promising regimen for the treatment of osteoporosis.

Romosozumab是一种骨形成剂,具有通过抑制硬化蛋白增加骨形成和减少骨吸收的双重作用。在绝经后骨质疏松妇女的关键骨折研究(FRAME)和扩展试验中,12个月的romosozumab导致持续性骨折,特别是新的椎体骨折,在denosumab治疗24个月后,复位获益和持续的BMD(骨密度)增加。罗莫索单抗加地诺单抗的顺序治疗可能是治疗骨质疏松症的一个有希望的方案。
{"title":"[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]","authors":"Kumiko Ono,&nbsp;Sakae Tanaka","doi":"10.20837/4201903357","DOIUrl":"https://doi.org/10.20837/4201903357","url":null,"abstract":"<p><p>Romosozumab is a bone-forming agent with a dual effect of increasing bone formation and decreasing bone resorption by inhibiting sclerostin. In the pivotal Fracture study in postmenopausal women with osteroposis(FRAME)and the extension trial, 12 months of romosozumab led to persistent fracture, especially new vertebral fracture, reduction benefit and ongoing BMD(bone mineral density)gains when follow 24 months of denosumab. The sequence therapy of romosozumab followed by denosumab may be a promising regimen for the treatment of osteoporosis.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 3","pages":"357-362"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37168089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[ASBMR topics from basic research.] [来自基础研究的ASBMR主题]
Pub Date : 2019-01-01 DOI: CliCa1901104107
Yoshifumi Takahata, Riko Nishimura

One of the major topics of ASBMR in this year was progress in research on "Bone and muscle crosstalk". It has been practically and clinically known that appropriate exercise has good effects on bones strength, however the mechanism is still elusive. In this ASBMR meeting, there were many reports that muscle-derived hormones, e.g. Irisin, β-aminoisobutyric acid(BAIBA)or Myostatin interact with skeletal cells. Especially, the report regarding Irisin was impressive. Moreover, several reports regarding new aspects of osteoblasts and bone formation were also interesting. In this report, we would like to introduce these interesting abstracts.

今年ASBMR的主要议题之一是“骨肌相声”的研究进展。实践和临床都知道适当的运动对骨骼强度有良好的影响,但其机制尚不清楚。在这次ASBMR会议上,有许多关于肌肉源性激素,如鸢尾素、β-氨基异丁酸(BAIBA)或肌生长抑制素与骨骼细胞相互作用的报道。特别是关于鸢尾素的报道令人印象深刻。此外,一些关于成骨细胞和骨形成的新方面的报道也很有趣。在本报告中,我们将介绍这些有趣的摘要。
{"title":"[ASBMR topics from basic research.]","authors":"Yoshifumi Takahata,&nbsp;Riko Nishimura","doi":"CliCa1901104107","DOIUrl":"https://doi.org/CliCa1901104107","url":null,"abstract":"<p><p>One of the major topics of ASBMR in this year was progress in research on \"Bone and muscle crosstalk\". It has been practically and clinically known that appropriate exercise has good effects on bones strength, however the mechanism is still elusive. In this ASBMR meeting, there were many reports that muscle-derived hormones, e.g. Irisin, β-aminoisobutyric acid(BAIBA)or Myostatin interact with skeletal cells. Especially, the report regarding Irisin was impressive. Moreover, several reports regarding new aspects of osteoblasts and bone formation were also interesting. In this report, we would like to introduce these interesting abstracts.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"104-107"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36808017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Metabolism of bone and calcium period in perinatal patients treated with glucocorticoids.] 糖皮质激素对围生期患者骨钙代谢的影响
Pub Date : 2019-01-01 DOI: CliCa19015761
Ikuko Tanaka

Pregnancy and child birth are possible even in young females with diseases to be treated with glucocorticoid by controlling disease activity and careful follow-up. There is no description about expectant and nursing mothers in the guide lines for glucocorticoid-induced osteoporosis published in many countries. Obtaining informed consent is more important for understanding the benefit and risk of the pregnancy and child birth during the glucocorticoid treatment in the female patients, to whom getting a child is very meaningful.

即使是患有糖皮质激素治疗的疾病的年轻女性,也可以通过控制疾病活动和仔细随访来怀孕和分娩。许多国家出版的糖皮质激素所致骨质疏松症指南中没有对孕妇和哺乳期母亲的描述。获得知情同意对于了解女性患者在糖皮质激素治疗期间怀孕和分娩的益处和风险更为重要,对她们来说,生孩子是非常有意义的。
{"title":"[Metabolism of bone and calcium period in perinatal patients treated with glucocorticoids.]","authors":"Ikuko Tanaka","doi":"CliCa19015761","DOIUrl":"https://doi.org/CliCa19015761","url":null,"abstract":"<p><p>Pregnancy and child birth are possible even in young females with diseases to be treated with glucocorticoid by controlling disease activity and careful follow-up. There is no description about expectant and nursing mothers in the guide lines for glucocorticoid-induced osteoporosis published in many countries. Obtaining informed consent is more important for understanding the benefit and risk of the pregnancy and child birth during the glucocorticoid treatment in the female patients, to whom getting a child is very meaningful.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"57-61"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36818598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Osteoporosis as a risk factor for cardiovascular disease.] [骨质疏松是心血管疾病的危险因素。]
Pub Date : 2019-01-01 DOI: 10.20837/4201902171
Shinsuke Yamada, Masaaki Inaba

Osteoporosis(OP)is associated with high risk for cardiovascular disease(CVD). Concomitant occurrence of both OP and CVD seems to result from common pathological mechanisms between bone system and vascular system. It is expected that therapeutic agent for OP may be effective not only in normalization of bone metabolism but also in reducing vascular calcification. I give an outline with the relationship between bone metabolism and vascular calcification including epidemiology, outbreak mechanism, and effect on vascular calcification of OP treatment.

骨质疏松症(OP)与心血管疾病(CVD)的高风险相关。OP和CVD的同时发生似乎是由骨骼系统和血管系统之间共同的病理机制引起的。希望治疗OP的药物不仅能使骨代谢正常化,还能减少血管钙化。概述骨代谢与血管钙化的关系,包括流行病学、发病机制、OP治疗对血管钙化的影响。
{"title":"[Osteoporosis as a risk factor for cardiovascular disease.]","authors":"Shinsuke Yamada,&nbsp;Masaaki Inaba","doi":"10.20837/4201902171","DOIUrl":"https://doi.org/10.20837/4201902171","url":null,"abstract":"<p><p>Osteoporosis(OP)is associated with high risk for cardiovascular disease(CVD). Concomitant occurrence of both OP and CVD seems to result from common pathological mechanisms between bone system and vascular system. It is expected that therapeutic agent for OP may be effective not only in normalization of bone metabolism but also in reducing vascular calcification. I give an outline with the relationship between bone metabolism and vascular calcification including epidemiology, outbreak mechanism, and effect on vascular calcification of OP treatment.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"171-177"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[In vivo detection of coronary artery calcification by optical coherence tomography.] 光学相干断层成像在体内检测冠状动脉钙化
Pub Date : 2019-01-01 DOI: 10.20837/4201902199
Yosuke Katayama, Takashi Kubo, Takashi Akasaka

Acute coronary syndromes are caused by sudden luminal thrombosis due to plaque rupture, plaque erosion, or calcified nodule in coronary atherosclerotic lesions. Coronary calcification is a well-known marker of atherosclerotic plaque burden. Accurate evaluation of coronary calcification is critical for percutaneous coronary intervention(PCI)strategy. Optical coherence tomography(OCT)is a high-resolution(10~20 μm)intravascular imaging technique that uses near infrared light to create images. OCT allows us to identify the details of coronary calcification and assess the effect of cutting balloon angioplasty and rotational atherectomy. Then, OCT is a useful technique to guide PCI in the severe calcified lesions.

急性冠脉综合征是由于冠状动脉粥样硬化病变中斑块破裂、斑块侵蚀或钙化结节引起的突然腔内血栓形成所致。冠状动脉钙化是众所周知的动脉粥样硬化斑块负荷的标志。准确评估冠状动脉钙化是经皮冠状动脉介入治疗(PCI)策略的关键。光学相干断层扫描(OCT)是一种高分辨率(10~20 μm)的血管内成像技术,使用近红外光成像。OCT使我们能够识别冠状动脉钙化的细节,并评估切割球囊血管成形术和旋转动脉粥样硬化切除术的效果。因此,在严重钙化病变中,OCT是指导PCI的有效技术。
{"title":"[In vivo detection of coronary artery calcification by optical coherence tomography.]","authors":"Yosuke Katayama,&nbsp;Takashi Kubo,&nbsp;Takashi Akasaka","doi":"10.20837/4201902199","DOIUrl":"https://doi.org/10.20837/4201902199","url":null,"abstract":"<p><p>Acute coronary syndromes are caused by sudden luminal thrombosis due to plaque rupture, plaque erosion, or calcified nodule in coronary atherosclerotic lesions. Coronary calcification is a well-known marker of atherosclerotic plaque burden. Accurate evaluation of coronary calcification is critical for percutaneous coronary intervention(PCI)strategy. Optical coherence tomography(OCT)is a high-resolution(10~20 μm)intravascular imaging technique that uses near infrared light to create images. OCT allows us to identify the details of coronary calcification and assess the effect of cutting balloon angioplasty and rotational atherectomy. Then, OCT is a useful technique to guide PCI in the severe calcified lesions.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 2","pages":"199-205"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36895572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Fate decision of hematopoietic stem cells by Wnt signaling.] [Wnt信号对造血干细胞命运的决定]
Pub Date : 2019-01-01 DOI: 10.20837/4201903343
Yoshio Katayama

Over the past 15 years, many studies have revealed that Wnt signaling has a strong impact on hematopoietic stem cell fate. After a controversy over the interpretation of some results, the current understanding is that an appropriate degree of canonical Wnt signaling induces hematopoietic stem cell self-renewal and that noncanonical Wnt signaling keeps the quiescence. It is also likely that the balance between canonical and noncanonical Wnt pathways regulates the stress response and aging of hematopoietic stem cells.

在过去的15年中,许多研究表明Wnt信号对造血干细胞的命运有很强的影响。在对一些结果的解释存在争议之后,目前的理解是适当程度的典型Wnt信号诱导造血干细胞自我更新,而非典型Wnt信号保持静止。规范化和非规范化Wnt通路之间的平衡也可能调节造血干细胞的应激反应和衰老。
{"title":"[Fate decision of hematopoietic stem cells by Wnt signaling.]","authors":"Yoshio Katayama","doi":"10.20837/4201903343","DOIUrl":"https://doi.org/10.20837/4201903343","url":null,"abstract":"<p><p>Over the past 15 years, many studies have revealed that Wnt signaling has a strong impact on hematopoietic stem cell fate. After a controversy over the interpretation of some results, the current understanding is that an appropriate degree of canonical Wnt signaling induces hematopoietic stem cell self-renewal and that noncanonical Wnt signaling keeps the quiescence. It is also likely that the balance between canonical and noncanonical Wnt pathways regulates the stress response and aging of hematopoietic stem cells.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 3","pages":"343-347"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37168087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[A meeting Report on the 2018 annual meeting of ASBMR-Clinical practice of the osteoporosis-.] [asbmr 2018年年会会议报告-骨质疏松症临床实践-]
Pub Date : 2019-01-01 DOI: CliCa1901108111
Reiko Watanabe, Daisuke Inoue

In the 2018 ASBMR annual meeting, many important results were reported, showing the effects of anti-osteoporotic drugs already focusing on bone quality and the concept of "treat-to-target", although there were few big topics on novel drugs. However, some reports on new drugs, such as probiotics and SARM(selective androgen receptor modulator), did draw attention.

在2018年ASBMR年会上,报告了许多重要的结果,表明抗骨质疏松药物的作用已经集中在骨质量和“治疗到目标”的概念上,尽管关于新药的大课题很少。然而,一些关于益生菌和选择性雄激素受体调节剂(SARM)等新药的报道引起了人们的注意。
{"title":"[A meeting Report on the 2018 annual meeting of ASBMR-Clinical practice of the osteoporosis-.]","authors":"Reiko Watanabe,&nbsp;Daisuke Inoue","doi":"CliCa1901108111","DOIUrl":"https://doi.org/CliCa1901108111","url":null,"abstract":"<p><p>In the 2018 ASBMR annual meeting, many important results were reported, showing the effects of anti-osteoporotic drugs already focusing on bone quality and the concept of \"treat-to-target\", although there were few big topics on novel drugs. However, some reports on new drugs, such as probiotics and SARM(selective androgen receptor modulator), did draw attention.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"108-111"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36808018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical features and diagnosis of lumbar fractures caused by pregnancy- and lactation-associated osteoporosis.] [妊娠及哺乳期骨质疏松所致腰椎骨折的临床特点及诊断]
Pub Date : 2019-01-01 DOI: CliCa19014650
Takuma Kuroda, Takashi Nagai, Koji Ishikawa, Katsunori Inagaki

Pregnancy- and lactation-associated osteoporosis is a rare disease. Although researchers have reported a few cases, there are no established diagnostic criteria for pregnancy- and lactation-associated osteoporosis. However, a diagnosis can be easily obtained by an accurate medical interview, physical examination, imaging studies, and laboratory data, including bone mineral density measurement. This disease should be suspected when a woman presents with severe back pain in the late stages of pregnancy or the early postpartum period. An accurate and prompt diagnosis helps with appropriate treatment and prevents the progression of the disease.

妊娠和哺乳期骨质疏松症是一种罕见的疾病。尽管研究人员已经报道了一些病例,但对于妊娠期和哺乳期相关的骨质疏松症尚无确定的诊断标准。然而,通过准确的医学访谈、体格检查、影像学研究和实验室数据,包括骨密度测量,可以很容易地得到诊断。当妇女在妊娠晚期或产后早期出现严重背痛时,应怀疑患有此病。准确和及时的诊断有助于适当的治疗并防止疾病的发展。
{"title":"[Clinical features and diagnosis of lumbar fractures caused by pregnancy- and lactation-associated osteoporosis.]","authors":"Takuma Kuroda,&nbsp;Takashi Nagai,&nbsp;Koji Ishikawa,&nbsp;Katsunori Inagaki","doi":"CliCa19014650","DOIUrl":"https://doi.org/CliCa19014650","url":null,"abstract":"<p><p>Pregnancy- and lactation-associated osteoporosis is a rare disease. Although researchers have reported a few cases, there are no established diagnostic criteria for pregnancy- and lactation-associated osteoporosis. However, a diagnosis can be easily obtained by an accurate medical interview, physical examination, imaging studies, and laboratory data, including bone mineral density measurement. This disease should be suspected when a woman presents with severe back pain in the late stages of pregnancy or the early postpartum period. An accurate and prompt diagnosis helps with appropriate treatment and prevents the progression of the disease.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"46-50"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36818596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical calcium
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1